健脾清化颗粒减少非糜烂性反流病患者PPI剂量:多中心随机双盲双模拟非劣效研究
该多中心随机双盲双模拟非劣效研究纳入204例非糜烂性反流病(NERD)患者,比较健脾清化(JQ)颗粒联合奥美拉唑10 mg与奥美拉唑20 mg的疗效。结果显示联合组第4周GERD Q完全缓解率40.8%优于PPI组的26.8%(FAS分析,OR 1.88;95%CI 1.03-3.44;p=0.039),充分缓解率两组差异无统计学意义,联合组还可增加肠道菌群丰富度和多样性并纠正谷氨酸代谢通路。
要点
- JQ颗粒联合奥美拉唑10 mg可提高NERD患者第4周完全缓解率
- 联合组充分缓解率与奥美拉唑20 mg组差异无统计学意义
- 联合组可出现肝功能障碍,需关注安全性
核心结论
- JQ颗粒联合奥美拉唑10 mg在NERD患者症状缓解方面优于奥美拉唑20 mg。
研究设计与样本
- 多中心、随机、双盲、双模拟、非劣效研究,共纳入204例患者,按1:1随机分为联合组和PPI组。
主要发现
- 第4周完全缓解率联合组为40.8%,PPI组为26.8%(FAS分析,OR 1.88;95%CI 1.03-3.44;p=0.039)。
- 第4周充分缓解率联合组为50%,PPI组为43.30%(FAS分析,OR 1.31;95%CI 0.74-2.30;p=0.35)。
- 联合组出现3例肝功能障碍,其中1例轻度、2例中重度。
- 联合组肠道菌群丰富度和多样性较PPI组显著增加。
- 代谢组学显示联合治疗可纠正谷氨酸代谢通路。
关键数值与推荐
- 联合组:JQ颗粒34.8 g+奥美拉唑10 mg+奥美拉唑模拟剂10 mg,每日一次,共4周。
- PPI组:JQ颗粒模拟剂34.8 g+奥美拉唑20 mg,每日一次,共4周。
临床怎么用
- 对于NERD患者,可考虑JQ颗粒联合奥美拉唑10 mg以在减少PPI剂量的同时提高症状完全缓解率。
- 治疗期间需监测肝功能,警惕肝功能障碍的发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Proton pump inhibitors (PPIs) play an important role in the treatment of nonerosive reflux disease (NERD), but their long-term and excessive uses have been associated with safety concerns. Chinese herbal medicine (CHM) has become a popular alternative treatment for this condition. METHODS: A total of 204 patients were randomly assigned to the combination group or PPI group (1:1 ratio). They were given JianpiQinghua (JQ) granules (34.8 g) plus omeprazole (10 mg) plus dummy omeprazole (10 mg) or dummy JQ granules (34.8 g) plus omeprazole (20 mg) daily for 4 weeks. The primary endpoints were the rate of sufficient relief and complete resolution of GERD Q at week 4. Metabonomics and the gut microbiota were also assessed. RESULTS: Complete resolution was observed in 40.8% of patients in the combination group and 26.8% of patients in the PPI group after 4 weeks (FAS analysis, OR, 1.88; 95% CI, 1.03-3.44; p = 0.039). Sufficient relief was observed in 50% of patients in the combination group and 43.30% of patients in the PPI group after 4 weeks (FAS analysis, OR, 1.31; 95% CI, 0.74-2.30; p = 0.35). Three patients had liver dysfunction, one of whom had a mild case and 2 of whom had moderate-to-severe cases in the combination group. Patients in the combination group showed a significant increase in richness and diversity of their gut microbiota compared with those in the PPI group. Metabonomics showed that the combination therapy could correct the glutamate metabolism pathway. CONCLUSION: Our findings demonstrate the superior efficacy of JQ granules combined with omeprazole (10 mg) vs. omeprazole (20 mg) in terms of symptom relief in patients with NERD. TRIAL REGISTRATION: ClinicalTrials.gov number NCT02892357. Registered on 14 February 2019.
引用
- Zhang J, Che H, Zhang B, et al. JianpiQinghua granule reduced PPI dosage in patients with nonerosive reflux disease: A multicenter, randomized, double-blind, double-dummy, noninferiority study. Phytomedicine. 2021. PMID: 34119741. doi:10.1016/j.phymed.2021.153584
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。